Is your attitude worth catching?
Biopharmaceutical industry comes through in dealing with Ebola
History Repeats with the Release of the 2019 WHO Essential Medicines List
Australia's National Medicines Policy is outdated and in need of review
HTA 2.0: time for a reboot
Five generations in the workplace: a moment in history
UHC and medicine price transparency feature at 2019 World Health Assembly
Shooting For the Stars: The Evolution in Outcome-Based Payment Models for Medicines
A minor issue?: minor parties and independents in the 2019 Australian election
Reflections on the art of political campaigning and advocacy
Should I Stay or Should I Go?: Brexit the Musical
Alzheimer's failure a lesson in why pharma companies are vital
How do we turn the tide?: Winning the measles vaccination debate
The WHO’s Essential Medicines List: Changing the Conversation
"We need to talk about pharma profits"
The elites vs the rest: can trust barometers predict political disruption?
Be careful what you wish for: cancer innovation and drug pricing
Brexit has gone to the dogs
The NHS 10-year plan: more artificial intelligence, less pigeon resuscitation
Targets, takeovers and Tomb Raiders: things to watch in 2019 global health policy